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Pre-eclampsia, fetal growth restriction and stillbirth are major pregnancy
disorders throughout the world. The underlying pathogenesis of these dis-
eases is defective placentation characterized by inadequate invasion of
extravillous placental trophoblast cells into the uterine arteries. How tropho-
blast invasion is controlled remains an unanswered question but is
influenced by maternal uterine immune cells called decidual natural killer
cells. Here, we describe an in vitro microfluidic invasion assay to study the
migration of primary human trophoblast cells. Each experiment can be per-
formed with a small number of cells making it possible to conduct research
on human samples despite the challenges of isolating primary trophoblast
cells. Cells are exposed to a chemical gradient and tracked in a three-
dimensional microenvironment using real-time high-resolution imaging, so
that dynamic readouts on cell migration such as directionality, motility and
velocity are obtained. The microfluidic system was validated using isolated
trophoblast and a gradient of granulocyte-macrophage colony-stimulating
factor, a cytokine produced by activated decidual natural killer cells. This
microfluidic model provides detailed analysis of the dynamics of trophoblast
migration compared to previous assays and can bemodified in future to study
in vitro how human trophoblast behaves during placentation.1. Introduction
During the first trimester of pregnancy in humans, the process of placentation
involves cells derived from the placenta, fetal extravillous trophoblasts (EVTs),
invading into the uterine wall in a controlled and directed manner. Here they
remodel the spiral arteries and convert them into highly dilated vessels capable
of providing sufficient nutrients and oxygen to the fetus (figure 1) [1]. Insuffi-
cient trophoblast invasion leads to deficient artery remodelling and is the
underlying cause of severe pregnancy disorders such as pre-eclampsia, still-
birth, fetal growth restriction and recurrent miscarriage [2,3]. A complex
network of cell signalling pathways including cytokines, oxygen tension and
cell–cell interactions regulate trophoblast invasion and placentation [4,5]. In
addition, distinctive maternal immune cells are only present in the uterine
mucosal lining, the decidua, during placentation. When these immune cells,
known as decidual natural killer (dNK) cells, are activated, they produce cyto-
kines such as granulocyte–macrophage colony-stimulating factor (GM-CSF)
that increase trophoblast migration. Therefore, to understand normal and dis-
ordered pregnancy requires an understanding of how maternal immune cells
migrating EVTs
dNK
cytokines
dNK cells
decidua
myometrium
placenta
Figure 1. Trophoblast invasion. The placenta implants into the maternal
decidua during the first trimester of pregnancy. Fetal extravillous trophoblasts
(EVTs) detach from the implanting placenta and invade the maternal decidua
to remodel uterine spiral arteries. Maternal leucocytes present at the
maternal– fetal interface, including decidual natural killer (dNK) cells, may
regulate trophoblast invasion and transformation of the spiral arteries by
secreting cytokines such as GM-CSF. (Online version in colour.)
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thus placentation.
Conventional methods to study trophoblast invasion both
in vivo and in vitro have significant drawbacks. There are
marked differences in the placentation of laboratory animals
when compared to humans, with the deep interstitial inva-
sion characteristic of humans only found in the great apes
[1]. Ex vivo explants of placentas suffer from poor viability
and difficulty in sampling across the whole placenta [6].
Existing in vitromethods include the Transwellw assay (Corn-
ing, Corning, NY, USA) where cells are placed in an insert
and migrate through a cell permeable membrane towards a
chemoattractant [7]. Alternatively, in the scratch assay a
gap is created by ‘scratching’ a monolayer of cells and the
migration rate determined by time lapse microscopy [8].
These in vitro assays are difficult to use with primary cells
because large numbers of purified trophoblast cells from
first trimester placentas are needed. Although cell lines (chor-
iocarcinoma cell lines JEG-3 and JAR) have been used in
migration assays [9–11], the expression profiles of these
malignant cells are quite different from primary EVTs [12].
Moreover, these in vitro assays are not a measure of true
chemotaxis, analysis of cell migration in two dimensions is
too simplified and as such they are considered to have low
physiological relevance [13,14].
In contrast to these existing migration assays, microfluidic
devices allow the precise control of chemical gradients
in a three-dimensional (3D) environment [15]. Cells are
embedded in a physiologically relevant hydrogel matrix,
and single cell chemotaxis is observed in real time under
constant fluid flow [16]. Individual cell migration tracks can
be quantified, and additional migration characteristics such
as cell speed and directionality can be obtained [17]. Impor-
tantly, because only a few thousand cells are required, this
assay can be performed using primary trophoblast cells.
Here, we describe a microfluidic device to study the
directed migration of primary human trophoblast cellsin vitro. The device was adapted from an assay to study
fibrosarcoma cancer cell migration [18], since trophoblast
and malignant cells share the characteristics of invasion
[19,20]. The device is composed of three channels, the central
one containing primary EVTs embedded in a hydrogel
matrix, with two flow through channels for delivery of
medium to either side of the gel. This method is validated
here using the response of EVTs to GM-CSF, to demonstrate
directed migration of primary trophoblast cells in a
three-dimensional environment.2. Material and methods
2.1. Fabrication of microfluidic device
Microfluidic devices were fabricated using soft lithography as
previously described [16]. The dimensions of each device are
4.5  2.3 cm with the length, width and height of each channel
of 20 300 mm, 1300 mm and 150 mm respectively. Ports are used
to access each channel and are made using a biopsy punch.
Fluid is withdrawn via channels A and B from two separate
reservoirs using a syringe pump (figure 2a).
Microfluidic devices were filled with EVTs in ice cold (08C)
Matrigelw (Corning, Corning, NY, USA). This hydrogel, a base-
ment membrane matrix was chosen as it contains collagen IV,
a protein shown to be present in the decidua and known to influ-
ence the invasive behaviour of trophoblast cells [21]. The gel was
allowed to polymerize at 378C for 45 min and then left overnight
at 378C before the start of an experiment. Experiments were
carried out at a constant flow rate of 50 ml h21 for 12 h.2.2. Imaging and gradient validation
For live-cell imaging and gradient checks, the LSM700 confocal
laser scanning microscope (Zeiss Oberkochen, Germany) includ-
ing the Zen software was used. The device and tubing were
maintained at 378C during imaging. For cell tracking, a scanning
range of 120 mm was chosen, ensuring that cells attached to the
bottom coverslip of the device were excluded. Z-stacks at five
positions in the central hydrogel area were acquired at 555 nm
every 20 min for a total of 12 h (figure 3a). For chemical gradient
validation identical positions and z-stacks were acquired at
488 nm. Fluorescein-conjugated dextran (40 kDa) at a flow rate
of 50 ml h21 was added to one of the two medium channels
and images taken over 12 h to visualize gradient generation.2.3. Analysis
To automatically track cells, the image processing software Fiji
(ImageJ, v. 2.0.0-rc-14/1.49 g) and the built-in plug-in TrackMate
(version 2.5.0) were used. To further analyse and interpret the
data a Matlab (Mathworks, Natick, MA, USA) script was devel-
oped that could quantify cell velocity, directionality and motility.
Directionality is given as the ratio of the net distance a cell moved
to the total distance migrated (figure 3b) [22]. Quantifying the
fraction of cells migrating downstream and subtracting these
from the fraction of cells migrating upstream determined motility
(figure 3c).2.4. Computational model
A finite-element model (FEM) was developed in Comsol Multi-
physics (COMSOL, Stockholm, Sweden) by importing the
device geometry from Auto-CAD (Autodesk, San Rafael, CA,
USA). The model was implemented to determine the molecular
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Figure 2. Microfluidics as a model for trophoblast invasion. EVTs are isolated from first trimester placentas, stained with a cell tracker and embedded in growth
factor-reduced Matrigel in the central hydrogel channel. (a) A constant flow of medium is applied in the two side channels, one with (channel A) and without
hrGM-CSF (channel B) to create a gradient of the cytokine across the hydrogel channel. Individual cell tracks are generated from time lapse microscopy. (b) To
confirm the purity of cells embedded in the microfluidic device, EVT were immune-stained for HLA-G (green) and the nucleus of each cell stained with DAPI
dye. (Online version in colour.)
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@C
@t
¼ Dr2Cr  ðvCÞ,
where C is the concentration, t is time, D is the diffusivity of
the solute, and v is the fluid velocity. The model solved the
diffusion equation for the full three-dimensional geometry of
the microfluidic device. The diffusivity was defined as 2 
10211 m2 s21 [23] and assumed to be constant throughout
the hydrogel region. The inlet concentration of the source
channel and the inlet flow rate were defined by the experimen-
tal values of 0.2 mol m23 and 1.4  1024 m s21, respectively,
and no-flux and no-slip boundary conditions were applied
at the PDMS walls.
2.5. Isolation of primary cells and cell seeding
Trophoblast and decidual leucocytes (DLs) were isolated from
placental and decidual samples from normal pregnancies
between 7 and 12 weeks of gestation using published protocols
[12,24]. Ethical approval was obtained from Cambridge
Local Research Ethics Committee (reference no. 04/Q0108/23;
Cambridge; United Kingdom).
Primary isolates of trophoblast cells were cultured in Fluoro-
brite DMEM medium (Thermo Fisher Scientific, Waltham, MA,
USA), supplemented with 20% fetal calf serum (FCS, Biosera,
Nuaille, France), 1 mM sodiumpyruvate (Thermo Fisher Scientific,
Waltham, MA, USA), 1 MEM non-essential amino acids,
2 mM l21 glutamine, 10 units ml21 penicillin, 100 mg ml21 strepto-
mycin and 2 mg ml21 gentamycin (Thermo Fisher Scientific,
Waltham, MA, USA). Following overnight culture on fibronectin-
coated wells, the cultures typically yield approximately 70–90%
EVTs identified by flow cytometry using an antibody specific for
HLA-G [24]. HLA-G is a HLA class I molecule uniquely expressedby invasive EVTs and is used to check purity of the isolated first
trimester cells. Trophoblast cells were labelled by incubation
with 40 mM cell tracker orange CMTMR (Thermo Fisher Scientific,
Waltham,MA, USA) for 15 min at 378C. EVTs at a concentration of
8  106 cells ml21 in cell medium were then embedded in a 1 : 1
mixture of Matrigel:cell solution. The volume of gel in the central
channel is approximately 2 ml with approximately 2000 cells
seeded. To generate a gradient of human recombinant (hr) GM-
CSF, 10 ng ml21 was added to the medium in channel A. Cells
were tracked in three dimensions by taking images every 20 min
for 12 h.
The dNK cells stochastically express polymorphic receptors
(Killer-cell Immunoglobulin-like receptors, KIR) that can impart
either an activating or inhibitory signal to the cell. The dNK
cells from different donors were genotyped to determine if
they possessed one of these KIR, the activating KIR2DS1 gene.
Briefly, genomic DNA was isolated from decidual samples
using the QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany).
The presence or absence of KIR2DS1 in each decidual sample
was determined by genotyping KIR from genomic DNA by
PCR as described previously [25,26]. dNK cells were isolated
from first trimester decidual samples of KIR2DS1þ and
KIR2DS12 donors. The isolates were cultured overnight in
RPMI1640 (Thermo Fisher Scientific, Waltham, MA, USA), anti-
biotics, 10% FCS and 2.5 ng ml21 Interleukin 15 (IL-15)
(Peprotech, Rocky Hill, NJ, USA). Enrichment for dNK cells
was performed using the EasySepTM Human NK Cell Enrich-
ment Kit (STEMCELL Technologies, Vancouver, Canada),
which uses magnetic beads to select for CD56þ cells. The
purity of dNK cells was established by staining for CD56-PE
(clone HCD56, Biolegend, San Diego, CA, USA) using flow cyto-
metry as described previously [27]. After enrichment of DL, the
purity of dNK cells increased from 48% to 85%.
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Figure 3. Image acquisition and analysis of individual cell tracks. (a) Primary EVTs embedded in Matrigel are subjected to a chemical gradient of hrGM-CSF for 12 h.
EVTs are tagged with a fluorescent cell tracker and imaged at five positions using an LSM 700 confocal microscope in the x, y and z-direction. Images are processed
with TrackMate (FIJI) and converted into cells tracks and then quantified into velocity, directionality and motility. The track colours are automatically generated by
TrackMate and have no significance. (b) Directionality is the ratio of the net distance a cell migrates over the total distance. (c) Motility is found by subtracting the
number of cells migrating upstream towards channel A (NA) by the number of cells migrating downstream (NB) away and dividing this by the total number of cells
(Nt). (Online version in colour.)
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of HLA-Gþ trophoblast cells
At the end of each experiment, trophoblast cells were identified
within the device by staining for HLA-G to determine purity
(figure 2b). The devices were washed with 1 PBS and incubated
with 4% paraformaldehyde (Sigma, St. Louis, MI, USA) for
30 min. The devices were blocked with 1% PBS and 2% normal
goat serum (Sigma, St. Louis, MI, USA) for 2 h followed by the
incubation with anti-HLA-G (clone G233-216, Quantum Biosys-
tems, Osaka, Japan) in 1 PBS at 48C overnight. The device
was washed twice with 1 PBS. FITC labelled Anti-HLA-G
(MEMG9-FITC, Bio-RAD, Kidlington, UK) and the nuclear
counterstain DAPI (Sigma, St Louis, MI, USA) were then
applied for 2 h. Four representative images across the hydrogel
channel after each experiment were acquired using a Zeiss LSM
700 (Zeiss, Oberkochen, Germany) confocal microscope. The
percentage of HLA-Gþ trophoblast cells was determined by
counting the total number of nuclei and the number of HLA-
Gþ cells. The average purity of isolated EVTs was 80% over
five experiments, in accordance with previous findings using
flow cytometry [28].2.7. Activation of decidual natural killer cells
To activate dNK cells, KIR receptors were cross-linked using
plate-bound antibodies. dNK cells from KIR2DS1þ donors
were isolated and used after overnight culture to remove adher-
ent cells. Eight-well strips (Sigma, St Louis, MI, USA) were
coated with 200 ml per well of 2.5 mg ml21 monoclonal antibody
(mAb), EB6 (CD158a, with specificity for KIR2DS1/KIR2DL1,
Beckman Coulter, High Wycombe, UK) or control human IgG
(Biolegend, San Diego, CA, USA) in 10 mM HEPES (PAA) over-
night at 48C. The dNK cells were plated at 2  105 cells per wellin RPMI1640, antibiotics, 10% FCS and 2.5 ng ml21 IL-15 and
cultured at 378C for 24 h. The supernatant was then collected
and GM-CSF was quantified using DuoSet ELISA (R&D Sys-
tems, Minneapolis, MN, USA) according to the manufacturer’s
instructions. The dNK supernatants obtained following acti-
vation of KIR2DS1þ dNK cells were diluted and used at a
GM-CSF concentration of 15 pg ml21.
2.8. Statistical analysis
Cell migration characteristics were analysed using Prism Soft-
ware (Graphpad, La Jolla, CA, USA). The unpaired t-test and
one-way analysis of variance (ANOVA) were used for the
hrGM-CSF and dNK supernatant experiments, respectively.
Significance is set as p , 0.05.3. Results
3.1. Establishing gradient in the microfluidic device
The chemical gradient between the two medium delivery
channels and the central channel containing cells was charac-
terized to determine whether a stable gradient was generated
and how long this gradient remained. The gradient gradually
built up until stabilizing after approximately 1 h and was
steady for at least 12 h (figure 4a). The FEM implemented
in COMSOL was used to characterize transport phenomena
in the device that corresponds to the 40 kDa dextran diffusing
inside the matrix (figure 4b). The computational model con-
firms the gradient profile is similar to the one observed
experimentally at 12 h with a linear gradient gradually build-
ing up after 1 h as shown by a plot of fluorescein intensity
measurements across the device at different time points
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Figure 4. Characterization of the chemical gradient across the hydrogel channel during constant fluid flow. (a) Fluorescein dextran of similar molecular weight to
human GM-CSF was added to the medium in channel A, constant fluid flow of 50 ml h21 per channel was applied, and the gradient was investigated for 12 h. The
gradient gradually builds up over a time period of 1 h and is stable for at least 12 h. (b) Computational model for gradient generation demonstrates similar gradient
at the device mid-plane at steady state to experimentally observed gradient 12 h. (c) Plot of fluorescein intensity across device, with width 1300 mm demonstrates
that linear gradient is established after 1 h. (d ) Plot of mean intensity and standard deviation (black bars) for four independent devices demonstrates linear gradient
in the central hydrogel region, with width 900 mm (each triangular post is 200 mm in length) is similar to the computationally predicted gradient (red line). C/C0 is
concentration of tracer normalized by the concentration in the media channel. (Online version in colour.)
rsif.royalsocietypublishing.org
J.R.Soc.Interface
14:20170131
5
 on June 4, 2017http://rsif.royalsocietypublishing.org/Downloaded from (figure 4c). To evaluate whether experimental and computa-
tionally predicted gradients are similar, the mean intensity
profiles of four independent devices were compared to the
gradient predicted by the FEM (figure 4d ). The overlay
demonstrates that linear gradients during microfluidic exper-
iments (black) are similar to the computationally predicted
gradient (red). C/C0 is concentration of tracer normalized
by the concentration in the media channel.3.2. Trophoblast cells in granulocyte-macrophage
colony-stimulating factor gradients
Recombinant GM-CSF, a product of activated dNK cells, has
previously been shown to enhance trophoblast invasion
using the Transwell assayw [29] and was used here to
validate migration of primary trophoblast cells in the micro-
fluidic device. Figure 5a shows plots of single cell migration
tracks (top) and the net direction of cells in polar histograms
(bottom) for control (no gradient) and hrGM-CSF gradients,
respectively. Data are shown for one representative device
of five repeats. There is undirected migration when hrGM-
CSF is absent. In contrast, hrGM-CSF induced a clear increase
in migration towards the channel with hrGM-CSF present.
The average migration velocity of EVTs with no gradient
over five samples is 6.52+0.91 mm h21. When the hrGM-
CSF gradient is present, the average migration velocity
significantly decreases to 6.26+ 0.74 mm h21 (electronic sup-
plementary material, figure S1) and trophoblast cells move
with significantly increased directionality, from 0.37 to 0.44
(figure 5c).
For each experiment, migration towards and away from
the concentration source was quantified. When hrGM-CSF
is added, a significantly larger fraction of EVTs migrates
towards this stimulus compared to the control, from 0.04 to0.73 (figure 5b). Thus, the hrGM-CSF gradient substantially
enhances the migratory behaviour of trophoblast cells.
3.3. Activation of decidual natural killer cells induces
trophoblast migration
We next asked whether cytokines and chemokines produced
following activation of dNK cells have the same positive
effect on trophoblast migration. The activating NK receptor,
KIR2DS1, is present in approximately 45% of donors.
Donors were typed for the presence/absence of the gene
and dNK cells expressing KIR2DS1 were activated using a
specific mAb (figure 6a) (§2.7). Similar to previous results
[29], GM-CSF production increased in the supernatants from
KIR2DS1þ but not KIR2DS12 donors compared to the control
(n ¼ 8) (figure 6b).
The dNK supernatants from KIR2DS1þ donors were
added to channel A to generate a gradient (figure 7a super-
natant I). In parallel, a GM-CSF neutralizing antibody was
added with the KIR2DS1þ supernatant to test whether
GM-CSF is the cytokine produced by activated dNK cells
that is causing trophoblast cells to migrate (figure 7a super-
natant II). In addition, supernatant from KIR2DS1þ donors
cross-linked with IgG control antibody was added to channel
A (figure 7a supernatant III). Trophoblast cells preferentially
migrated with increased directionality (figure 7b) and moti-
lity (figure 7c) towards the supernatants obtained from
activating dNK cells compared to random migration in the
supernatants with negative control containing IgG antibody
(n ¼ 5). Increase in directionality was diminished with the
addition of the GM-CSF neutralizing antibody, whereas
the motility decreased but not to the same level of the
negative control. Thus, activation of maternal dNK cells
does result in increased trophoblast migration and this is
partially due to GM-CSF.
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Figure 5. Recombinant hrGM-CSF stimulates the migration of human extravillous trophoblasts (EVTs). (a) Cell tracks and polar histograms show the random
migration of EVTs in the control compared to directed migration when 10 ng ml21 GM-CSF is added to channel A. A representative experiment is shown out
of five performed. Only cells that migrated more than 30 mm were analysed. Cells migrating towards channel A (hrGM-CSF) and towards channel B (no
hrGM-CSF) are coloured blue and red, respectively. Polar histograms visualize the number of cells that migrate in different directions (inner radial axis). The
outer radial axis represents migration angles. (b) The difference of cell fractions migrating towards and away from hrGM-CSF was quantified. Significantly
more cells migrate towards GM-CSF when exposed to 10 ng ml21 hrGM-CSF (n ¼ 5). (c) Trophoblast cells migrate with increased directionality in the presence
of GM-CSF. *p , 0.05 calculated using the unpaired t-test. (Online version in colour.)
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In this study, microfluidic devices have been used to quantify
the migratory characteristics of primary trophoblast cells to
model EVTmigration, which is a critical period in humanpreg-
nancy. In previous work [29] GM-CSF was shown to be a
chemoattractant for EVTs; this new approach allows for accu-
rate quantification of migration of individual cells in response
to the chemoattractant. In addition, activation of dNK cells
through anNK receptor, KIR2DS1, results inGM-CSF secretion
that enhances the directional migration of trophoblast cells.
This illustrates how maternal uterine immune cells can affect
placentation, and how this microfluidics assay approach can
be used for biological studies of trophoblast migration.
Although invasion of the uterus by trophoblast cells plays
a critical role in reproductive outcome, limited understanding
of the mechanisms controlling trophoblast invasion remains
a major obstacle to progress in pregnancy research [20,30].
Learning more about what factors influence trophoblast inva-
sion and the cellular and molecular basis of the invasion
pathway is essential. Reliable and reproducible methods to
study how trophoblast behaviour is controlled, and that can
be used in different laboratories with primary cells is lacking.Strategies to improve methods to study cell migration have
come from the cancer field, since cancer cells spread through
tissues [31–33]. Microfluidics has been used to study various
aspects of tumour biology such as intravasation [18], extrava-
sation [34], angiogenesis [35], tumour–stroma interactions
[36], tumour cell migration in response to chemotaxis [37],
matrix stiffness [38] and interstitial flow [39]. In addition, can-
didate molecules and drugs to target cancer metastasis can be
tested using microfluidic devices because of the low cost of
reagents and manufacturing the devices, together with the
high throughput nature of testing [40,41].
The microfluidic device used here has been adapted to
observe and quantify trophoblast. Both single cell and collec-
tive migration, together with quantification of migration
speed and directionality, provide key advantages over con-
ventional assays used to study EVTs. Each assay can be
performed with a small number of cells, which makes it poss-
ible to conduct research on human samples given the
challenges of isolating sufficient number of pure primary
HLAGþ EVTs from first trimester placentas.
To validate migration of EVTs in the microfluidic device,
a gradient of hrGM-CSF (previously shown by us to enhance
trophoblast migration in a Transwellw assay [29]) was
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negative control (supernatant III). (b) Trophoblast cells migrate with increased directionality towards supernatants produced by activated KIR2DS1þ dNK cells.
Directed migration is reduced when anti-GM-CSF neutralizing antibody is added. (c) A large fraction of cells migrate towards increasing concentrations of
supernatants produced by activated KIR2DS1þ dNK cells. *p , 0.05 calculated using one-way analysis of variance (ANOVA) and Dunn’s multiple comparisons
test. (Online version in colour.)
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resolution imaging, the velocity of trophoblast migration is
similar to that of invasive cancer cells [42,43]. In the absence
of a chemical gradient, the movement of EVTs is undirected
but with a chemical gradient of hrGM-CSF, trophoblast
moves with increased directionality and motility but reducedvelocity towards the GM-CSF positive control. Immunohisto-
chemistry for HLA-G was performed after each experiment to
assess the purity of EVTs in the population. In future it
should be possible to retrieve cells from the central hydrogel
channel for other techniques such as gene expression and
flow cytometric analysis.
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 on June 4, 2017http://rsif.royalsocietypublishing.org/Downloaded from Having established the microfluidics platform as viable
for the study of trophoblast migration, more complex
biological questions can be asked. Maternal KIR genes are
highly polymorphic and it is unclear how the presence or
absence of particular KIR in different women translates into
a functional effect on trophoblast cells early in gestation
[25,26]. Previous genetic studies show that an activating NK
receptor, KIR2DS1, protects women from pre-eclampsia and
KIR2DS1þ dNK cells promote trophoblast cell migration
in vitro compared to women who only express the inhibitory,
KIR2DL1 [25,26]. The results in this study are consistent with
this model. The activation of KIR2DS1þ dNK cells resulted in
significantly higher secretion of GM-CSF than KIRDS12
dNK cells when compared to the negative IgG controls
[29]. A larger fraction of trophoblast cells migrated towards
supernatants secreted from KIR2DS1þ dNK cells with
increased directionality and motility compared to random
migration in the control. To determine if GM-CSF in the
supernatant was responsible for this effect, the addition of
anti-GM-CSF antibody resulted in a reduction in the direc-
tionality and motility of cells migrating towards the
concentration source. Therefore, GM-CSF is a key cytokine
in the regulation of trophoblast invasion by dNK cells but
other factors not yet definitively identified are clearly
involved as the migration was not completely blocked by
the anti-GM-CSF antibody. This microfluidic migration
assay provides a three-dimensional model for trophoblast
invasion through the extracellular matrix (ECM) involving
highly regulated and reciprocal interactions between ECM
and cells. Because the migration response is governed
by the ability of a cell to degrade the ECM, it is important
to ask whether the ECM used in this study is truly
representative of decidual matrix components. During the
transformation of endometrium to decidua to prepare the
uterine lining for implantation and pregnancy, there is a pro-
found change in the ECM with a large increase in collagen IV
and laminin surrounding endometrial stromal cells, which
are the main protein components of Matrigel, the basement
membrane used in this study [44,45]. In addition, the decidua
contains collagen type I, III and VI, which are diffusively dis-
tributed in the endometrium throughout the cycle [46,47].
Moreover, the basement membrane at the end of the first tri-
mester surrounding each decidual stromal cell contains
fibronectin and heparin sulphate proteoglycan meaning that
ECM components present in the decidua are more varied
than in Matrigel. A second important question is whether
the mechanical stiffness of the hydrogel surrounding the
cells is representative of decidual tissue. The mechanicalenvironment is known to influence cellular responses includ-
ing adhesion and migration, as cells are able to convert
mechanical input into complex intracellular signalling cas-
cades and downstream protein expression [48]. However,
the mechanical stiffness of decidua remains uncharacterized
and there are variations in the reported stiffness of Matrigel
[49,50]. Therefore, more work in future is needed to better
understand both the mechanical and molecular properties
of the decidua and to design a gel that better represents the
tissue trophoblast cells migrate through in vitro.5. Conclusion
This study has described a new approach to study human
trophoblast invasion. By using a bioengineering approach,
we have retained the physiological relevance of trophoblast
cells invading in three dimensions. This was done while
adding analysis of the dynamics of cell migration, which is
not possible in conventional assays and animal models.
This study goes further than previous work to add greater
quantification on GM-CSF as a chemoattractant for EVT
migration. With the use of microfluidic devices there is
potential to further investigate the complex physiochemical
influences on trophoblast behaviour during placentation.
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